Celgene

Sun Pharma settles patent dispute with US-based Celgene Corporation

Pharma major Sun Pharmaceutical Industries Ltd. on Tuesday said it along with one of its subsidiaries have reached an agreement with Celgene Corporation (Celgene) to resolve a patent litigation.

Updated On: 22 Jun 2021 | 10:09 AM IST

premium

Natco Pharma's Canadian unit, Celgene sign pact for cancer treatment drug

Lenalidomide drug is used to treat various types of cancers by slowing or stopping the growth of aberrant cells

Updated On: 10 Jul 2020 | 1:49 PM IST

Celgene to acquire Impact Biomedicines for up to $7 billion

Celgene is interested in Impact Biomedicines' fedratinib that has shown promise as a potential treatment for a type of blood cancer

Updated On: 09 Jan 2018 | 2:31 AM IST